Wolverine Trading’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Wolverine Trading’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-22,500	Closed	-$545K	–	5240
2023 Q1	$545K	Buy	+22,500	New	+$282K	﹤0.01%	2429
2022 Q4	–	Sell	-43,700	Closed	-$194K	–	5390
2022 Q3	$194K	Buy	43,700 +14,900	+52%	+$67.9K	﹤0.01%	3641
2022 Q2	$113K	Buy	+28,800	New	+$137K	﹤0.01%	3800
2022 Q1	–	Sell	-18,600	Closed	-$107K	–	6809
2021 Q4	$107K	Buy	+18,600	New	+$118K	﹤0.01%	5071
2021 Q3	–	Sell	-13,700	Closed	-$116K	–	7249
2021 Q2	$116K	Buy	+13,700	New	+$111K	﹤0.01%	5330

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wolverine Trading's PRVB Position: Q2 2023 in Review

Wolverine Trading sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 11,023 shares — an estimated $267K sold.

Wolverine Trading first reported a position in PRVB in Q2 2021 and held it in 4 quarters. The position peaked at $299K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Wolverine Trading reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Wolverine Trading sold 11,023 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $267K.
Wolverine Trading first reported a position in Provention Bio, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Wolverine Trading's Provention Bio, Inc. Common Stock position peaked at $299K in Q2 2021.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.